Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Trivedi PJ, Bowlus CL, Yimam KK, Razavi H, Estes C. Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies. Clin Gastroenterol Hepatol. 2022;20(8):1687.e4–1700.e4. https://doi.org/10.1016/j.cgh.2021.08.039
2. Choudhary NS, Saigal S, Thummala S, Saraf N, Rastogi A, Bhangui P, et al. Good long-term outcomes in patients with primary sclerosing cholangitis undergoing living donor liver transplantation. J Clin Exp Hepatol. 2020;10(5):442–447
3. Ueda Y, Kaido T, Okajima H, Hata K, Anazawa T, Yoshizawa A, et al. Long-term prognosis and recurrence of primary sclerosing cholangitis after liver transplantation: a single-center experience. Transpl Direct. 2017;3(12): e334
4. Egawa H, Taira K, Teramukai S, Haga H, Ueda Y, Yonezawa A, et al. Risk Factors for Recurrence of Primary Sclerosing Cholangitis After Living Donor Liver Transplantation: A Single Center Experience. Dig Dis Sci. 2009;54(6):1347–1354
5. Gordon FD, Goldberg DS, Goodrich NP, Lok ASF, Verna EC, Selzner N, et al. Recurrent PSC in the A2ALL Study: Comparison of Risk Factors Between Living and Deceased Donor Recipients. Liver Transpl Off Publ Am Assoc Study Liver Dis Int Liver Transpl Soc. 2016;22(9):1214–1222
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献